Literature DB >> 14668699

The relation of insulin resistance syndromes to risk of cardiovascular disease.

Richard W Nesto1.   

Abstract

Diabetes mellitus is one of the most common problems challenging physicians in the 21st century. Type 2 diabetes mellitus accounts for at least 90% of all cases, which can be attributed in part to an aging population and the prevalence of obesity and sedentary lifestyles. In addition to the major impact on quality of life, diabetes accounts for a significant proportion of global healthcare expenditure, with the majority of costs attributable to treatment of its long-term complications. The principal cause of diabetes mortality is cardiovascular disease (CVD). There is a long period, prior to clinical detection of the disease, in which insulin resistance and hyperglycemia gradually worsen, and vascular complications develop. This article reviews the relationship between diabetes and the risk of CVD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668699

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  17 in total

1.  High sensitivity C-reactive protein, tumor necrosis factor-α, interleukin-6, and vascular cell adhesion molecule-1 levels in Asian Indians with metabolic syndrome and insulin resistance (CURES-105).

Authors:  Karunakaran Indulekha; Jayagopi Surendar; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

2.  Inflammation and the metabolic syndrome.

Authors:  Praveen Sharma
Journal:  Indian J Clin Biochem       Date:  2011-11-01

3.  Relationship between Metabolic Syndrome Components and Severity of Asthma in Outpatients Referring to Alzahra Hospital Clinic.

Authors:  Mohammad Emami-Ardestani; Ghazaleh Sajadi
Journal:  Tanaffos       Date:  2021-04

4.  Effect of aging on muscle mitochondrial substrate utilization in humans.

Authors:  Kitt Falk Petersen; Katsutaro Morino; Tiago C Alves; Richard G Kibbey; Sylvie Dufour; Saki Sono; Peter S Yoo; Gary W Cline; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

5.  Circulating TNFrII levels predict incidence of ischemic heart disease and total mortality, independently of intima media thickness and pulse wave velocity in male with type 2 diabetes.

Authors:  Martina Ak Johansson; Camilla Vavruch; Carl Johan Östgren; Fredrik H Nystrom
Journal:  Heart Vessels       Date:  2021-04-19       Impact factor: 2.037

6.  Simplified, Low-Cost Method on Glucose Tolerance Testing in High-Risk Group of Diabetes, Explored by Simulation of Diagnosis.

Authors:  Kan Shao; Gong Chen; Cheng Chen; Shan Huang
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

7.  Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial.

Authors:  Tayyebeh Kermani; Seyyed Hadi Mousavi; Maryam Shemshian; Abdolreza Norouzy; Mohsen Mazidi; Atefeh Moezzi; Toktam Moghiman; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Avicenna J Phytomed       Date:  2015 Sep-Oct

8.  The association between metabolic syndrome and vascular endothelial dysfunction in adolescents.

Authors:  Ying Wei; Geli Liu; Jingyan Yang; Rongxiu Zheng; Lihong Jiang; Pengli Bao
Journal:  Exp Ther Med       Date:  2013-04-09       Impact factor: 2.447

Review 9.  Redefining the role of thiazolidinediones in the management of type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  Cardiometabolic aspects of polycystic ovarian syndrome.

Authors:  Li Wei Cho; Harpal S Randeva; Stephen L Atkin
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.